Donia M - Search Results

1

New perspectives in HCV therapy: entry inhibitors.

Donia M, Cacopardo B, Libra M, Scalia G, McCubrey JA, Nicoletti F. Donia M, et al. Recent Pat Antiinfect Drug Discov. 2010 Nov;5(3):181-94. doi: 10.2174/157489110793348802. Recent Pat Antiinfect Drug Discov. 2010. PMID: 20497122 Review.

2

Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.

Libra M, Mangano K, Anzaldi M, Quattrocchi C, Donia M, di Marco R, Signorelli S, Scalia G, Zignego AL, de Re V, Mazzarino MC, Nicoletti F. Libra M, et al. Among authors: donia m. Oncol Rep. 2006 May;15(5):1305-8. Oncol Rep. 2006. PMID: 16596202

3

In vitro inhibition of enterobacteria-reactive CD4+CD25- T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027.

Mangano K, Sardesai N, D'Alcamo M, Libra M, Malaguarnera L, Donia M, Bendtzen K, Meroni P, Nicoletti F. Mangano K, et al. Among authors: donia m. Eur J Pharmacol. 2008 May 31;586(1-3):313-21. doi: 10.1016/j.ejphar.2008.02.017. Epub 2008 Feb 17. Eur J Pharmacol. 2008. PMID: 18374912

4

Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells.

Mijatovic S, Maksimovic-Ivanic D, Mojic M, Malaponte G, Libra M, Cardile V, Miljkovic D, Harhaji L, Dabideen D, Cheng KF, Bevelacqua Y, Donia M, Garotta G, Al-Abed Y, Stosic-Grujicic S, Nicoletti F. Mijatovic S, et al. Among authors: donia m. Nitric Oxide. 2008 Sep;19(2):177-83. doi: 10.1016/j.niox.2008.04.004. Epub 2008 May 19. Nitric Oxide. 2008. PMID: 18460348

5

The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.

Donia M, Mijatovic S, Maksimovic-Ivanic D, Miljkovic D, Mangano K, Tumino S, Biondi A, Basile F, Al-Abed Y, Stosic-Grujicic S, Nicoletti F. Donia M, et al. Eur J Pharmacol. 2009 Aug 1;615(1-3):228-33. doi: 10.1016/j.ejphar.2009.04.069. Epub 2009 May 14. Eur J Pharmacol. 2009. PMID: 19446546

6

Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.

Donia M, Mangano K, Amoroso A, Mazzarino MC, Imbesi R, Castrogiovanni P, Coco M, Meroni P, Nicoletti F. Donia M, et al. J Autoimmun. 2009 Sep;33(2):135-40. doi: 10.1016/j.jaut.2009.06.003. Epub 2009 Jul 21. J Autoimmun. 2009. PMID: 19625166

7

Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Mangano K, Nicoletti A, Patti F, Donia M, Malaguarnera L, Signorelli S, Magro G, Muzio V, Greco B, Zaratin P, Meroni P, Zappia M, Nicoletti F. Mangano K, et al. Among authors: donia m. Clin Exp Immunol. 2010 Feb;159(2):159-68. doi: 10.1111/j.1365-2249.2009.04050.x. Epub 2009 Nov 18. Clin Exp Immunol. 2010. PMID: 19922500 Free PMC article.

8

Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO.

Mijatovic S, Maksimovic-Ivanic D, Timotijevic G, Miljkovic D, Donia M, Libra M, Coco M, McCubrey J, Al-Abed Y, Korac A, Stosic-Grujicic S, Nicoletti F. Mijatovic S, et al. Among authors: donia m. Free Radic Biol Med. 2010 Apr 15;48(8):1090-9. doi: 10.1016/j.freeradbiomed.2010.01.026. Epub 2010 Jan 28. Free Radic Biol Med. 2010. PMID: 20114073

9

Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs.

Steelman LS, Abrams SL, Shelton JG, Chappell WH, Bäsecke J, Stivala F, Donia M, Nicoletti F, Libra M, Martelli AM, McCubrey JA. Steelman LS, et al. Among authors: donia m. Cell Cycle. 2010 Apr 15;9(8):1629-38. doi: 10.4161/cc.9.8.11487. Epub 2010 Apr 15. Cell Cycle. 2010. PMID: 20372086 Free PMC article.

10

Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Abrams SL, Steelman LS, Shelton JG, Chappell W, Bäsecke J, Stivala F, Donia M, Nicoletti F, Libra M, Martelli AM, McCubrey JA. Abrams SL, et al. Among authors: donia m. Cell Cycle. 2010 May;9(9):1839-46. doi: 10.4161/cc.9.9.11544. Epub 2010 May 15. Cell Cycle. 2010. PMID: 20436269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

517 results

Search Page